Prognostic and predictive value of the Immunoscore in stage III colon cancer patients treated with oxaliplatin in the prospective IDEA France PRODIGE-GERCOR cohort study-Reference-Cited by-同舟云学术

Prognostic and predictive value of the Immunoscore in stage III colon cancer patients treated with oxaliplatin in the prospective IDEA France PRODIGE-GERCOR cohort study

Published:2020-07 Issue:7 Volume:31 Page:921-929
ISSN:0923-7534
Container-title:Annals of Oncology
language:en
Short-container-title:Annals of Oncology

Author:

Pagès F.^ORCID,André T.,Taieb J.,Vernerey D.,Henriques J.,Borg C.,Marliot F.,Ben Jannet R.,Louvet C.,Mineur L.,Bennouna J.,Desrame J.,Faroux R.,Kirilovsky A.,Duval A.,Laurent-Puig P.,Svrcek M.,Hermitte F.,Catteau A.,Galon J.,Emile J.-F.

Funder

Institut National Du Cancer

Institut National de la Santé et de la Recherche Médicale

Publisher

Elsevier BV

Subject

Oncology,Hematology

Reference22 articles.

1. Oxaliplatin, fluorouracil, and leucovorin as adjuvant treatment for colon cancer;André;N Engl J Med,2004

2. Adjuvant fluorouracil, leucovorin, and oxaliplatin in stage II to III colon cancer: updated 10-year survival and outcomes according to BRAF mutation and mismatch repair status of the MOSAIC study;André;J Clin Oncol,2015

3. Duration of adjuvant chemotherapy for stage III colon cancer;Grothey;N Engl J Med,2018

4. Three versus 6 months of oxaliplatin-based adjuvant chemotherapy for patients with stage III colon cancer: disease-free survival results from a randomized, open-label, International Duration Evaluation of Adjuvant (IDEA) France, phase III Trial;André;J Clin Oncol,2018

5. Role of deficient DNA mismatch repair status in patients with stage III colon cancer treated with FOLFOX adjuvant chemotherapy: a pooled analysis from 2 randomized clinical trials;Zaanan;JAMA Oncol,2018

Cited by 117 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Immunotherapeutic strategies for the treatment of colorectal cancer;Principles of Immunotherapy Breast and Gastrointestinal Cancers;2025

2. Benefit of adjuvant chemotherapy on recurrence free survival per consensus molecular subtype in stage III colon cancer;International Journal of Cancer;2024-08-08

3. Evaluation of CD3 and CD8 T-Cell Immunohistochemistry for Prognostication and Prediction of Benefit From Adjuvant Chemotherapy in Early-Stage Colorectal Cancer Within the QUASAR Trial;Journal of Clinical Oncology;2024-07-31

4. Machine learning evaluation of immune infiltrate through digital tumour score allows prediction of survival outcome in a pooled analysis of three international stage III colon cancer cohorts;eBioMedicine;2024-07

5. Clinical significance of combined tumour-infiltrating lymphocytes and microsatellite instability status in colorectal cancer: a systematic review and network meta-analysis;The Lancet Gastroenterology & Hepatology;2024-07